Neuronetics_logo-RGB purple.png
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
August 20, 2024 08:29 ET | Neuronetics
MALVERN, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge
August 12, 2024 07:15 ET | Neuronetics
MALVERN, Pa. and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”) today announced that they have...
Neuronetics_logo-RGB purple.png
Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results
August 12, 2024 07:10 ET | Neuronetics
MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of...
Neuronetics_logo-RGB purple.png
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 05, 2024 16:36 ET | Neuronetics
MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics_logo-RGB purple.png
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
August 01, 2024 08:29 ET | Neuronetics
MALVERN, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference
July 31, 2024 08:30 ET | Neuronetics
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors
July 30, 2024 08:30 ET | Neuronetics
MALVERN, Pa., July 30, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call
July 29, 2024 08:30 ET | Neuronetics
MALVERN, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
July 22, 2024 08:31 ET | Neuronetics
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics_logo-RGB purple.png
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
July 11, 2024 08:36 ET | Neuronetics
MALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...